Market closed

Biodesix/BDSX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Biodesix

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Ticker

BDSX
Trading on

Industry

Health Care Providers & Services

Employees

217

Biodesix Metrics

BasicAdvanced
$245M
Market cap
-
P/E ratio
-$0.45
EPS
1.22
Beta
-
Dividend rate
$245M
1.22
$2.21
$1.15
202K
3.28
2.982
170.416
172.637
-3.61%
-21.41%
-304.17%
2.751
6.77
17.1
-2.739
46.25%
-56.80%
-7.51%
-36.36%

What the Analysts think about Biodesix

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Biodesix stock.

Biodesix Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Biodesix Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy BDSX

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Biodesix stock?

Biodesix (BDSX) has a market cap of $245M as of October 05, 2024.

What is the P/E ratio for Biodesix stock?

The price to earnings (P/E) ratio for Biodesix (BDSX) stock is 0 as of October 05, 2024.

Does Biodesix stock pay dividends?

No, Biodesix (BDSX) stock does not pay dividends to its shareholders as of October 05, 2024.

When is the next Biodesix dividend payment date?

Biodesix (BDSX) stock does not pay dividends to its shareholders.

What is the beta indicator for Biodesix?

Biodesix (BDSX) has a beta rating of 1.22. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.